关注
Krutika Kuppalli
标题
引用次数
引用次数
年份
A living WHO guideline on drugs for covid-19
A Agarwal, B Rochwerg, F Lamontagne, RAC Siemieniuk, T Agoritsas, ...
9662022
Virology, transmission, and pathogenesis of SARS-CoV-2
M Cevik, K Kuppalli, J Kindrachuk, M Peiris
bmj 371, 2020
9272020
Lemierre's syndrome due to Fusobacterium necrophorum
K Kuppalli, D Livorsi, NJ Talati, M Osborn
The Lancet infectious diseases 12 (10), 808-815, 2012
2942012
Spectrum of CNS disease caused by rapidly growing mycobacteria
NJ Talati, N Rouphael, K Kuppalli, C Franco-Paredes
The Lancet infectious diseases 8 (6), 390-398, 2008
742008
A glimpse into the eye of the COVID-19 cytokine storm
K Kuppalli, AL Rasmussen
EBioMedicine 55, 2020
662020
Neurological and psychiatric presentations associated with human monkeypox virus infection: a systematic review and meta-analysis
JB Badenoch, I Conti, ER Rengasamy, CJ Watson, M Butler, Z Hussain, ...
EClinicalMedicine 52, 2022
632022
India's COVID-19 crisis: a call for international action
K Kuppalli, P Gala, K Cherabuddi, SP Kalantri, M Mohanan, B Mukherjee, ...
The Lancet 397 (10290), 2132-2135, 2021
632021
New nomenclature for mpox (monkeypox) and monkeypox virus clades
D Ulaeto, A Agafonov, J Burchfield, L Carter, C Happi, R Jakob, ...
The Lancet Infectious Diseases 23 (3), 273-275, 2023
552023
The UK needs a sustainable strategy for COVID-19
D Gurdasani, L Bear, D Bogaert, RA Burgess, R Busse, R Cacciola, ...
The Lancet 396 (10265), 1800-1801, 2020
332020
Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ 371: m3862
M Cevik, K Kuppalli, J Kindrachuk, M Peiris
Retrieved 2021-05-24, from https://www. bmj. com/content/371/bmj. m3862 doi …, 2020
332020
Gender disparities in coronavirus disease 2019 clinical trial leadership
M Cevik, SA Haque, J Manne-Goehler, K Kuppalli, PE Sax, MS Majumder, ...
Clinical Microbiology and Infection 27 (7), 1007-1010, 2021
322021
Cultural competence and humility in infectious diseases clinical practice and research
SA Hussen, K Kuppalli, J Castillo-Mancilla, R Bedimo, N Fadul, I Ofotokun
The Journal of infectious diseases 222 (Supplement_6), S535-S542, 2020
162020
COVID-19 vaccine acceptance: we need to start now
K Kuppalli, DM Brett-Major, TC Smith
Open Forum Infectious Diseases 8 (2), ofaa658, 2021
132021
Appropriate usage of face masks to prevent SARS-CoV-2: Sharpening the messaging amid the COVID-19 pandemic
K Escandón, GP Martin, K Kuppalli, K Escandón
Disaster Medicine and Public Health Preparedness 15 (4), e5-e7, 2021
72021
Gender disparities in international COVID-19 clinical trial leadership
M Cevik, SA Haque, J Manne-Goehler, K Kuppalli, PE Sax, MS Majumder, ...
medRxiv, 2020.08. 02.20166751, 2020
42020
Mpox in children and adolescents during multicountry outbreak, 2022–2023
A Hoxha, SM Kerr, H Laurenson-Schafer, N Sklenovská, BB Mirembe, ...
Emerging Infectious Diseases 29 (10), 2125, 2023
32023
Emergency committee recommendations on mpox–what’s next?
RF Lewis, K Kuppalli, A Hoxha, MC Doherty
Bulletin of the World Health Organization 101 (5), 300, 2023
32023
Towards a coordinated strategy for intercepting human disease emergence in Africa
KM Forbes, O Anzala, CJ Carlson, AA Kelvin, K Kuppalli, EM Leroy, ...
The Lancet Microbe 2 (2), e51-e52, 2021
32021
Successful treatment of SARS-CoV-2 in an immunocompromised patient with persistent infection for 245 days: A case report
V Overbeck, BP Taylor, J Turcinovic, X Qiu, B Schaeffer, S Seitz, SR Curry, ...
Heliyon 10 (1), 2024
22024
Hostility Unmasked: Scientists on the Frontlines of the COVID-19 Pandemic
K Kuppalli
Clinical Infectious Diseases 78 (5), 1097-1098, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20